Patou Gary's Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Nov 28, 2022
- Accession no.
- 0001209191-22-058916
- Filed
- Nov 28, 2022
- Trade date
- Nov 23-25, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $138.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patou GaryCIK 0001283535 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2022 | Common Shares | SSaleDisposed | −2,057 | $34.33 | −$70,616.81 | 23,573 | Direct | |
| Nov 25, 2022 | Common Shares | MOption exerciseAcquired | +2,057 | $2.68 | +$5,512.76 | 25,630 | Direct | |
| Nov 25, 2022 | Common Shares | FTax withholdingDisposed | −120 | $34.37 | −$4,124.4 | 25,510 | Direct | |
| Nov 25, 2022 | Common Shares | SSaleDisposed | −1,937 | $34.79 | −$67,388.23 | 23,573 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2022 | Common Shares | MOption exerciseDisposed | −2,057 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.